To further understand how the inclusion of additional antigens from the M.tb life cycle enhance protection against pulmonary M.tb infection, we generated a bivalent ChAd:TB vaccine expressing Ag85A and TB10.4, herein referred to as Biv:ChAd:TB (Fig. 3D). This evidence concerns the gene TMSB10 and tuberculosis.